CN Patent
CN110946834B — 枸橼酸托法替布片及其制备工艺
Assigned to Sichuan Kelun Pharmaceutical Research Institute Co Ltd · Expires 2023-03-31 · 3y expired
What this patent protects
本发明属于药物制剂领域,本发明提供的枸橼酸托法替布片由填充剂,崩解剂,润滑剂,包衣材料及药学上可接受的其它辅料组成。该片剂杂质含量低,长期放置稳定性较好,且工艺操作简单、生产效率高、重现性好,有利于工业化大生产。
USPTO Abstract
本发明属于药物制剂领域,本发明提供的枸橼酸托法替布片由填充剂,崩解剂,润滑剂,包衣材料及药学上可接受的其它辅料组成。该片剂杂质含量低,长期放置稳定性较好,且工艺操作简单、生产效率高、重现性好,有利于工业化大生产。
Drugs covered by this patent
- Xeljanz (Tofacitinib Citrate) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.